J. Scott Sawyer

Recent Advances in Diaryl Ether Synthesis

J. Scott Sawyer · Tetrahedron · 2000 · 306 citations

Natural Sciences, Chemistry, Medicinal Chemistry +6

Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain

J. Scott Sawyer, Bryan D. Anderson, Douglas W. Beight et al. · Journal of Medicinal Chemistry · 2003 · 237 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor

Jonathan M. Yingling, William T. McMillen, Lei Yan et al. · Oncotarget · 2017 · 173 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Physical properties and synthetic utility of .alpha.-alkoxyorganolithium species as studied through ligand selectivity in tin-lithium exchange

J. Scott Sawyer, Andrew Kucerovy, Timothy L. Macdonald et al. · Journal of the American Chemical Society · 1988 · 164 citations

Natural Sciences, Chemistry, Inorganic Chemistry +10

Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain

J. Scott Sawyer, Douglas W. Beight, Karen S. Britt et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 163 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14